Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (290K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
ASTRUP T. The biological significance of fibrinolysis. Lancet. 1956 Sep 15;271(6942):565–568.[PubMed]
KREVANS JR, JACKSON DP. Hemorrhagic disorder following massive whole blood transfusions. J Am Med Assoc. 1955 Sep 17;159(3):171–177.[PubMed]
MACPHERSON AI, LEARMONTH J. The operative risk in diseases of the haematopoietic system and defects in coagulation. Scott Med J. 1956 Jan;1(1):32–38.[PubMed]
PROUT GR, SIEGEL M, CLIFFTON EE, WHITMORE WF., Jr Hemorrhagic diathesis in patients with carcinoma of prostate. J Am Med Assoc. 1956 Mar 10;160(10):840–846.[PubMed]
SCOTT EV, MATTHEWS WF, BUTTERWORTH CE, Jr, FROMMEYER WB., Jr Abnormal plasma proteolytic activity; diagnosis and treatment. Surg Gynecol Obstet. 1954 Dec;99(6):679–688.[PubMed]
STEFANINI M, CAMPBELL EW, PLITMAN GI, SALOMON L. Coagulation defects due to acquired anticoagulants and fibrinolysis; their detection and treatment. Bull New Engl Med Cent. 1953 Mar;15(1):23–31.[PubMed]
DANIEL O, SWAN HT, WOOD KF. Dangerous bleeding associated with carcinoma of prostate. Br Med J. 1957 Mar 2;1(5017):495–498.[PMC free article][PubMed]
Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press